Ocular manifestations of HIV/AIDS

Current Opinion in Ophthalmology

Volumn 13, Issue 6, 2002, Pages 397-403

  Moraes Jr , Haroldo V ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Departamento de Oftalmologia   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANGIOGENESIS INHIBITOR; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; ATOVAQUONE; CIDOFOVIR; FAMCICLOVIR; FOMIVIRSEN; FOSCARNET; GANCICLOVIR; IDOXURIDINE; PENICILLIN G; PYRIMETHAMINE; SULFONAMIDE; VALACICLOVIR; VALGANCICLOVIR; VIDARABINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLINDNESS; CELLULITIS; CHOROIDITIS; CLINICAL TRIAL; COCCIDIOIDOMYCOSIS; CYTOMEGALOVIRUS INFECTION; EYE DISEASE; FUNGAL MENINGITIS; HERPES SIMPLEX VIRUS; HERPES ZOSTER OPHTHALMICUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; KERATITIS; KERATOPATHY; LYMPHOCYTE COUNT; LYMPHOMA; MICROSPORIDIOSIS; MILIARY TUBERCULOSIS; MOLLUSCUM CONTAGIOSUM; MYCOBACTERIOSIS; PNEUMOCYSTOSIS; PRIORITY JOURNAL; RETINA MACULOPATHY; RETINITIS; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA; THRUSH; TOXOPLASMOSIS; VARICELLA ZOSTER VIRUS; VIRUS REPLICATION; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; EYE DISEASES; HUMANS; INCIDENCE; RISK FACTORS;

EID: 0036892185     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200212000-00010     Document Type: Review

References (39)

1. Centers for Disease Control and Prevention: The global HIV and AIDS epidemic, 2001. MMWR 2001, 50:434-439.
2. JAMA HIV/AIDS Information Center website: www.ama-assn.org/special/hiv/hivhome.htm. Accessed: February 2, 2002.
3. Joint United Nations Program on HIV/AIDS: AIDS Epidemic Update. Geneva: UNAIDS, December 2000 and 2001.
4. Cunningham ET Jr, Belfort R Jr: HIV/AIDS and the Eye: Global Perspective California. AAO, 2002.
5. Hsieh SM, Pan SC, Hung CC, et al: Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. J Infect Dis 2001, 184:1386-1391.
6. Komanduri KV, Feinberg J, Hutchins RK, et al: Loss of cytomegalovirus-specific CD4+ T cell counts and recurrent retinitis. J Infect Dis 2001, 183:1285-1289.
7. Tyring S Engst R, Corriveau C, et al: The Collaborative Famciclovir Ophthalmic Zosler Research Group. Br J Ophthalmol 2001, 85:576-581.
8. Colin J, Prisant O, Cochener B, et al: Comparison of the efficacy of valacycrovir and acyclovir for the treatment of herpes zoster ophthalmicus. Ophthalmology 2000, 107:1507-1511.
9. Dezube BJ; New therapies for the treatment of AIDS-related Kaposi sarcoma. Curr Opn Oncol 2000, 12:445-449.
10. Thomas JO: Acquired immunodeficiency syndrome-associated cancers in Sub-Saharan Africa. Semin Oncol 2001, 28:198-206.
11. Jabs DA: Acquired immunodeficiency syndrome. In Ocular Infection and Immunity. Edited by Pepose JS, Holland GN, Wilhelmus KR. St Louis: Mosby-Year Book 1996, 289-310.
12. Shah GK, Cantrill HL, Holland EJ: Vortex keratopathy associated with atovaquone. Am J Ophthalmol 1995, 120:669-671.
13. Lucca JA, Harris RL, Bielory L, et al: Keratoconjunctivitis sicca in male patients infected with human immunodeficiency virus type 1. Ophthalmology 1990, 97:1008-1010.
14. Tschachler E, Bergstresser PR, Stingl G: HIV-related skin diseases. Lancet 1996, 348:659-663.
15. Cunningham ET Jr: Uveitis in HIV positive patients. Br J Ophthalmol 2000, 84:233-235.
16. Cunningham ET Jr, Margolis TP: Ocular manifestations of HIV infection. N Engl J Med 1998, 339:236-244.
17. Kestelyn PG, Cunningham ET Jr: HIV/AIDS and blindness. Bull World Health Organ 2001, 79:208-213.
18. Vitravene Study Group: Safety of intravenous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDS. Am J Ophthalmol 2002, 133:475-483.
19. Vitravene Study Group: Randomized dose-comparison studies of intravenous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS. Am J Ophthalmol 2002, 133:467-474.
20. Chou S, Miner RC, Drew WL: A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance. J Infect Dis 2000, 182:1765-1768.
21. Song MK, Karavellas MP, MacDonald JC, et al: Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy. Retina 2000, 20:151-155.
22. Song MK, Schrier RD, Smith IL, et al: Paradoxical activity of CMV retinitis in patients receiving highly active antiretroviral therapy. Retina 2002, 22:262-267.
23. Jacobson MA, Shrier R, McCune JM, et al: Cytomegalovirus(CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy. J Infect Dis 2001, 183:1399-1404.
24. The Sudies of Ocular Complications of AIDS Research Group. Use of filgrastim as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis. AIDS 2002, 29;16:757-765.
25. Monoclonal Antibody Cytomegalovirus Retinitis Trial. AIDS 2002, 16:877-887. Assesses the importance of HIV viral load.
26. Belfort R Jr: The ophthalmologist and the global impact of the AIDS epidemic. LV Edward Jackson memorial Lecture. Am J Ophthalmol 2000, 129:1-8.
27. Martin DF, Sierra-Madero J, Walmsley S, et al: A controlled trial of valganciclovir as induction for cytomegalovirus retinitis. N Engl J Med 2002, 346:1119-1126.
28. Moraes HV Jr: Discontinuation of specific treatment for cytomegalovirus retinitis in patients who have responded to HAART. Rev Bras Oftalmol 2002, submitted for publication.
29. Berenguer J, Gonzalez J, Pulido F, et al: Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy. Clin Infect Dis 2002, 34:394-397.
30. Jouan M, Saves M, Tubiana R, et al: Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS 2001, 15:23-31.
31. Robinson MR, Ross ML, Whitcup SM: Ocular manifestations of HIV infection. Curr Opin Ophthalmol 1999, 10:431-437.
32. Moraes HV Jr: Punctate outer retinal toxoplasmosis in an HIV-positive child. Ocul Immunol Inflamm 1999, 7: 93-95.
33. Cunningham ET Jr, Levinson RD, Jampol LM, et al: Ischemic maculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 2001, 132:727-733.
34. Karavellas Mp, Azen Sp, MacDonald JC, et al: Immune recovery vitreitis and uveitis in AIDS: Clinical predictors, sequelae, and treatment outcomes. Retina 2001, 21:1-9.
35. Robinson MR, Reed G, Csaky KG, et al: Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Ophthalmol 2000, 130:49-56.
36. Nguyen QD, Kempes JH, Bolton SG, et al: Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol 2000, 129:634-639.
37. Nussenblatt RB, Lane HC: Human immunodeficiency virus disease: Changing patterns of intra-ocular inflammation. Am J Ophthalmol 1998, 125:374-382.
38. Tardieu M. HIV-1-related central nervous system diseases. Curr Opin Neurol 1999, 12:377-381.
39. Dehenny PJ, Warman R, Flynn JT: Ocular manifestations in pediatric patients with acquired immunodeficiency syndrome. Arch Ophthalmol 1989, 107:978-982.